Christopher Brooke's Insider Trades & SAST Disclosures
Christopher Brooke's most recent trade in Aytu BioPharma Inc was a trade of 7,000 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Aug. 11, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Christopher Brooke.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aytu BioPharma Inc | Christopher Brooke | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2023 | 7,000 | 7,000 | - | - | Employee Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges